Immunotherapy post-surgery improves overall survival for kidney cancer
For the first time in fifty years, results from a phase 3 randomised, placebo-controlled trial…
For the first time in fifty years, results from a phase 3 randomised, placebo-controlled trial…
Copper is an essential trace element required to produce energy in the body and allows…
Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the…
A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup…
Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the…
One of the biggest challenges treating kidney cancer is the wide number of tumour types…
Researchers at the Francis Crick Institute, The Royal Marsden NHS Foundation Trust, UK, and UCL,…
An experimental drug already shown to be safe and help some patients with clear cell…
Scientists report promising activity of a novel drug that targets a key molecular driver of…